GlassScriptPhysician profile
Matthew A Corriere
NPI 1861509325
$2,014.26
in general payments reported to CMS, 2019-2025
7 companies · $673 in 2025
The $673 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $288 · 2022: $110 · 2023: $312 · 2024: $442 · 2025: $673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,426.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,304.71 | 2020-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis With Heparin |
| Silk Road Medical, INC. | $189.92 | 2019 | |
| Medtronic Vascular, INC. | $143.88 | 2020 | |
| Penumbra, INC. | $131.00 | 2025 | Indigo System |
| Medtronic, INC. | $109.58 | 2022 | |
| Bolton Medical INC | $102.02 | 2024-2025 | Treo Abdominal Stent-Graft System |
| Bard Peripheral Vascular, INC. | $33.15 | 2024 | Lutonix Drug Coated Balloon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Corriere listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.